Want to join the conversation?
Pharma company $SCLN and biopharma company Soligenix said they have signed a license deal granting rights to $SCLN to develop, promote, market, distribute and sell SGX942, being developed for treating oral mucositis in patients with head and neck cancer. The deal includes China, Hong Kong and Macau, as well as Taiwan, South Korea and Vietnam.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.
$FHN shares have dropped after its earnings missed analysts’ expectations. I’m worried whether the stock will slide further.